Live! #39 — Sustaining EU MDR and IVDR certification in the post-market phase - What will it take? - podcast episode cover

Live! #39 — Sustaining EU MDR and IVDR certification in the post-market phase - What will it take?

Aug 27, 202145 minTranscript available on Metacast
--:--
--:--
Listen in podcast apps:

Episode description

This is the audio-only version of RQM+ Live! #39, originally recorded 26 August, 2021.

The climb to MDR certification is well underway for device manufacturers. It's been quite an undertaking, but with careful planning, budgeting and execution, it has and will lead to continued successful commercialization of medical devices and IVD’s in the EU. However, achieving certification is just the beginning. Compared to the MDD and IVDD, it will be quite challenging keeping up with all the new requirements for post-market reporting and documentation updates that these trigger. And although many IVD manufacturers are just getting started on the journey to IVDR certification, given the sheer volume of new requirements, the earlier you to start preparing for the post-market phase the better.

With heftier regulatory files to maintain, highly detailed clinical evaluations and PMCF/PMPF plans, many new PMS reporting requirements, and expectations for much more coordinated review of and updates to regulatory, clinical, and risk documentation at a higher frequency than ever before, it's critical to start considering how all of this will be accomplished in the years ahead. Something like a "simple" design change may never have the word simple in front of it again when considering the impact of any product modification across functions and documentation.

In this show we'll talk about what life will look like for regulatory, clinical, quality and PMS functions as we enter MDR/IVDR sustaining mode, and continue to support getting new products to market. Please bring your questions for our experts… we're here to help!

The panel will include:

  • Amie Smirthwaite, Ph.D. - Global VP, Clinical Regulatory Services
  • Nancy Morrison, RAC - Executive Director, Regulatory and Quality Consulting Services
  • Jon Gimbel, Ph.D. - Executive Director, Regulatory and Quality Consulting Services

-

About RQM+

RQM+ is the leading international provider of regulatory, quality and compliance consulting services for medical device and diagnostics manufacturers. The company delivers transformative solutions by providing unrivaled collective expertise fueled by passion for client success. The experts at RQM+ are collaborative, laser-focused on client needs and committed to delivering high-value solutions that exceed expectations. For more information, please visit RQMplus.com.